Pet Cancer Therapeutics Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast to 2027

 The pet cancer therapeutics market is speculated to garner considerable gains by 2027 due to rising pet care expenditure across the globe.

Surging prevalence of cancer among pets has augmented the need for more comprehensive predictive animal models, which has led to an increase in R&D activities in pet cancer therapeutics. Moreover, growing awareness among pet owners regarding pet diseases and therapeutics has propelled industry adoption in recent years.

Notably, industry players have been implementing lucrative initiatives to monetize emerging trends in the market, which has favorably impacted overall business dynamics. For instance, in January 2021, Anivive Lifesciences, a key pharmaceutical company specializing in pet therapeutics, received FDA approval for its novel antineoplastic therapeutic, dubbed the LAVERDIA-CA1. LAVERDIA-CA1 is the first canine-specific small-molecule selective inhibitor of nuclear export (SINE) medication for lymphoma.

To access a sample copy or view the market report in detail along with the table of

contents, please click the link below: https://www.gminsights.com/request-sample/detail/2017

The pet cancer therapeutics market has been segmented on the basis of application, therapy, species, route of administration, and region. With respect to therapy, the market has further been categorized into combination therapy, chemotherapy, targeted therapy, and immunotherapy.

In 2020, the targeted therapy sub-segment accounted for a sizable market share with a valuation of more than USD 32 million and is slated to progress at a steady pace over 2021-2027. The versatility of the procedure, coupled with novel advancements in the field of targeted cancer therapy, is estimated to boost segmental growth through the assessment period.

By route of administration, the market has been classified into injection and oral. The pet cancer therapeutics industry share from the oral sub-segment recorded a valuation of nearly USD 80 million in 2020 and is set to observe sturdy expansion over the study timeline. This growth is attributed to the ease of administration of drugs through oral methods.

Browse key industry insights spread across xx pages with 184 market data tables & 18 figures & charts from the report, “Pet Cancer Therapeutics Market Size By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy), By Route of Administration (Oral, Injection), By Species (Dogs, Cats), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer), COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market

From the species point of view, the pet cancer therapeutics market has been divided into cats and dogs. The dogs sub-segment held the lion's share of around 95% in the market in 2020 and is projected to expand at a robust pace through the forecast timeframe. Rising prevalence of cancer among dogs and significant developments in the diagnosis and management of canine cancer are likely to foster segmental outlook over the following years.

In terms of application, the pet cancer therapeutics market has been segregated into mammary and squamous cell cancer, lymphoma, melanoma, mast cell cancer, and others. The melanoma sub-segment is anticipated to exceed a valuation of USD 96 million by the end of 2027 on account of mounting incidences of melanoma.

On the regional front, the Latin America pet cancer therapeutics industry was worth over USD 1.8 million in 2020 and is poised to witness optimistic development due to rising awareness among pet owners regarding pet cancer diagnostics and therapeutics.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology

1.1    Market definition

1.2    Base estimates & working

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

Chapter 2   Executive Summary

2.1    Pet cancer therapeutics industry 3600 synopsis, 2016 - 2027

2.1.1    Business trends

2.1.2    Therapy trends

2.1.3    Route of administration trends

2.1.4    Species trends

Browse complete table of content of this report@ https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com 

Web: https://www.gminsights.com/industry-reports/healthcare-and-medical-devices